Journal: BMC Cancer
Article Title: Serum CD26 levels in patients with gastric cancer: a novel potential diagnostic marker
doi: 10.1186/s12885-015-1757-0
Figure Lengend Snippet: CD26 serum levels in patients with gastric cancer ( n = 30) and in control healthy individuals ( n = 24). Patients serum CD26 levels: 557.7 ± 118.3 pg/mL; control serum CD26 levels: 703.4 ± 170.3 pg/mL. * p = 0.001 by unpaired t test
Article Snippet: The concentration of serum CD26 were analyzed using a specific immunoassays (Human CD26/DPP4 ELISA Kit, Boster biological technology, Pleasanton, CA) ELISAs were performed according to the manufacturer’s instructions: mean values of duplicated measurements were calculated and a sigmoid-shaped standard curve was determined by simultaneously analyzing a dilution series of standard samples.
Techniques: Control